ASLAN Pharmaceuticals to Participate in the 2021 Cantor Virtual Global Healthcare Conference

Rhea-AI Summary

ASLAN Pharmaceuticals (Nasdaq: ASLN) announced that Dr. Carl Firth, CEO, will present at the 2021 Cantor Virtual Global Healthcare Conference on September 30, 2021, at 9:20 AM ET. The conference takes place from September 27 to September 30, 2021. A live webcast of the presentation will be available on ASLAN's Investor Relations website and will be archived for 365 days. ASLAN is focused on developing innovative treatments in immunology, including its candidates ASLAN004 and ASLAN003 for atopic dermatitis and autoimmune diseases, respectively.

MENLO PARK, Calif., and SINGAPORE, Sept. 22, 2021 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced Dr Carl Firth, CEO, is scheduled to give a company presentation at the 2021 Cantor Virtual Global Healthcare Conference on September 30, 2021, at 9:20am ET. The conference will be held from September 27 to September 30, 2021.

A live webcast of the presentation will be available on September 30 at 9:20am ET and a replay will be archived for 365 days. To access the webcast, go to the News & Events section in ASLAN’s Investor Relations website at www.ir.aslanpharma.com or the following link: https://wsw.com/webcast/cantor12/asln/2083340

Media and IR contacts

Emma Thompson Spurwing Communications Tel: +65 6206 7350 Email: ASLAN@spurwingcomms.com

Ashley R. Robinson LifeSci Advisors, LLC Tel: +1 (617) 430-7577 Email: arr@lifesciadvisors.com

About ASLAN Pharmaceuticals
ASLAN Pharmaceuticals (Nasdaq:ASLN) is a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients. ASLAN is currently evaluating ASLAN004, a potential first-in-class antibody targeting the IL-13 receptor, in atopic dermatitis, and ASLAN003, a potent oral inhibitor of DHODH, which is being developed for autoimmune disease. ASLAN has a team in Menlo Park, California, and in Singapore. For additional information please visit www.aslanpharma.com or follow ASLAN on LinkedIn.

FAQ

What is the date of the ASLN presentation at the 2021 Cantor Virtual Global Healthcare Conference?

The ASLN presentation is scheduled for September 30, 2021, at 9:20 AM ET.

Where can I watch the ASLN presentation from the Cantor Conference?

The ASLN presentation can be watched live through the Investor Relations section of ASLAN's website.

What are the main focus areas of ASLAN Pharmaceuticals?

ASLAN Pharmaceuticals focuses on developing innovative immunology treatments, particularly for atopic dermatitis and autoimmune diseases.

What is the purpose of the 2021 Cantor Virtual Global Healthcare Conference?

The conference is designed to showcase insights and advancements in the healthcare sector, featuring multiple presentations.

What are ASLAN004 and ASLAN003?

ASLAN004 is an antibody targeting the IL-13 receptor, and ASLAN003 is an oral inhibitor being developed for autoimmune diseases.